Health
British pharma firm claims small trial on a coronavirus treatment could signal ‘major breakthrough’ – CNBC
British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.
British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.
The company said its nebulizer treatment produced a 79% lower risk of patients developing severe disease than those given a placebo in initial trials, and patients that received the treatment “were more than twice as likely to recover (defined as ‘no limitation of activities’ or ‘no clinical or vi…
-
General14 hours agoVote counting begins for Townsville mayoral by-election
-
Business23 hours agoWhat $10,000 invested in CBA shares could be worth in 12 months
-
Noosa News19 hours agoQueensland GPs to be able to diagnose adults with attention deficit hyperactivity disorder from December 1
-
Noosa News22 hours agoTrump reverses course on beef tariff as pressure builds over cost of living